This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
City of London will be hosting its annual Wealth Management awards next month.
We hope your experience with Accendo Markets over the past 12 months warrants a vote in the following category; “BEST EXECUTION ONLY CFD PROVIDER”
_____________________________________________________________________________
| 888 Holdings | Investec ups TP to 185p from 135p, Buy |
| Andor Technology | Investec ups TP to 500p from 460p, Buy |
| Associated British Foods | Nomura ups TP to 1800p from 1790p, neutral |
| Bwin.Party Digital Entertainment | Investec ups TP to 140p from 100p |
| Dechra Pharmaceuticals | Investec ups TP to 733p from 670p, Buy |
| HSBC Holdings | Exane BNP Paribas ups TP by 13 percent to 850p |
| Ladbrokes | Nomura ups TP to 203p from 150p, neutral |
| Lloyds | SocGen removes from premium list |
| Pearson | SocGen cuts TP to 1040p from 1070p, sell |
| Pearson | Nomura cuts TP to 1195p from 1230p, reduce |
| Pearson | Exane BNP Paribas cuts TP by 10 percent to 1400p |
| Rathbone Brothers | Canaccord Genuity ups TP to 1500p from 1350p, Hold |
| Reckitt Benckiser | SocGen ups TP to 4000p from 3500p, sell |
| St. James’s Place | Berenberg initiates with Hold rating; TP 540p |
| Standard Chartered | Exane BNP Paribas ups TP by 10 percent to 1700p |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research